← Feed

BIENAIME JEAN JACQUES

SEC Form 4 insider
Ascendis Pharma A/S ($ASND)
1 thesis · first seen Aug 19, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$ASNDSEC Form 4bullish
BIENAIME JEAN JACQUES · Ascendis Pharma A/S · 4h agono track record yet
Long 2,000 shares of ASND
Bought 2,000 @ $246.33 avg · $492,654 · 2026-08-14

Form 4: BIENAIME JEAN JACQUES bought ASND

BIENAIME JEAN JACQUES (Director at Ascendis Pharma A/S) reported an open-market purchase of 2,000 shares of ASND at an average $246.33, roughly $492,654, in a Form 4 filed 2026-08-18.

View filing on SEC.gov →

End of results.